1
Home
Companies

Bruker

#2390

Rank

$5.92B

Marketcap

US United States

Country

Bruker
Leadership team

Dr. Frank H. Laukien Ph.D. (Chairman, CEO & Pres)

Mr. Gerald N. Herman (Exec. VP & CFO)

Dr. Mark R. Munch Ph.D. (Corp. Exec. VP and Pres of Bruker Nano Group & Corp.)

Products/ Services
Chemical, Life Science, Manufacturing, Medical
Number of Employees
1,000 - 20,000
Headquarters
Madison, Wisconsin, United States
Established
1960
Company Registration
SEC CIK number: 0001109354
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
BRKR
Social Media
URL
https://www.bruker.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
History

The company was founded on September 7, 1960, in Karlsruhe, Germany as Bruker-Physik AG by five people, one of them being Günther Laukien, who was a professor at the University of Karlsruhe at the time. The name Bruker originates from co-founder Emil Bruker, as Günther Laukien himself was formally not allowed to commercialize his research whilst being a professor. Bruker produced Nuclear Magnetic Resonance Spectroscopy and EMR spectroscopy equipment then.

In the early 1960s, the company had around 60 employees and was growing rapidly. One of the early success products was the HFX 90 NMR spectroscopy system, with three independent channels and which was also the first NMR system using only semiconductor transistors.In 1969, Bruker launched the first commercial Fourier transform NMR spectroscopy system and in the 1970s the company was the first to commercialize a superconducting FT-NMR. Later, the company would expand their product range with MRI, FTIR and FT-Raman spectrometers and with mass spectrometers.In 1968, Bruker shipped NMR systems to Yale University in Connecticut. After that, demand from the US grew, so Bruker opened an office in Elmsford, New York which marked the start of their US activities. In 2008 after a corporate reorganization lasting 8 years, all divisions were merged in a unified Bruker Corporation.Günther Laukien died in 1997; one of his four sons Frank Laukien, is currently the CEO of Bruker. Another son, Jörg C. Laukien, also works for the company. Another son, Dirk D. Laukien, is a former company executive.

Mission
Our ultimate mission is to enable significant advancements in the world’s sciences, technologies and industries, to open up new potentials and possibilities, and to promote progress, education and development in all areas of society.
Vision
Bruker's vision is to build strong, long-term relationships with our customers, based on trust and on an understanding of our customers’ need for life-changing technology, reliable service and innovative solutions.
Key Team

Mr. Juergen Srega (Pres of Bruker CALID Group & Bruker Daltonics Division)

Dr. Falko Busse Ph.D. (Pres of Bruker BioSpin Group)

Stacey Desrochers (Treasurer & Director of Investor Relations)

Mr. Urban Faeh (Pres of Bruker Optics Division & Managing Director of Bruker Optik GmbH)

Mr. Justin Joseph Ward (Sr. Director of Investor Relations & Corp. Devel.)

Mr. J. Brent Alldredge J.D. (Gen. Counsel)

Mr. Collin J. D'Silva (Pres of Chemical Analysis Division)

Recognition and Awards
Bruker has been presented with numerous awards for its outstanding customer service and innovative technology, such as the Frost & Sullivan Customer Service Leadership Award and the International Society of Environmental Sciences award.
References

https://en.wikipedia.org/wiki/Bruker

https://in.investing.com/equities/bruker

https://finance.yahoo.com/quote/BRKR/profile?p=BRKR

https://www.crunchbase.com/organization/bruker

https://companiesmarketcap.com/

https://www.bruker.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Bruker
Leadership team

Dr. Frank H. Laukien Ph.D. (Chairman, CEO & Pres)

Mr. Gerald N. Herman (Exec. VP & CFO)

Dr. Mark R. Munch Ph.D. (Corp. Exec. VP and Pres of Bruker Nano Group & Corp.)

Products/ Services
Chemical, Life Science, Manufacturing, Medical
Number of Employees
1,000 - 20,000
Headquarters
Madison, Wisconsin, United States
Established
1960
Company Registration
SEC CIK number: 0001109354
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
BRKR
Social Media
URL
https://www.bruker.com